Month: January 2022

STAMFORD, Conn., Jan. 20, 2022 (GLOBE NEWSWIRE) — HCM Acquisition Corp (the “Company”), a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, announced today that it has priced its initial public offering of 25,000,000 units at $10.00 per unit. The units will be listed on the Nasdaq Global Market (“Nasdaq”) and will begin trading tomorrow, January 21, 2022, under the ticker symbol “HCMAU.” Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant is exercisable to purchase one Class A ordinary share of the Company at a price of $11.50 per share. Only whole warrants are exercisable and will trade. Once the securities...

CINCINNATI, Jan. 20, 2022 (GLOBE NEWSWIRE) — LSI Industries (NASDAQ: LYTS or “LSI”), a leading U.S. based manufacturer of indoor/outdoor lighting and display solutions, announced today that one of the nation’s largest supermarket chains has selected JSI Store Fixtures, a wholly-owned subsidiary of LSI, to manufacture refrigerated display fixtures for approximately 800 stores. The $17 million customer order is expected to be fulfilled in its entirety during the second half of fiscal 2022. “We’re pleased JSI was chosen for these refrigerated displays,” said James A. Clark, President and CEO of LSI Industries. “This relationship is the result of the collaborative approach between JSI and the client to develop custom display solutions that are energy efficient, effective, and create a welcoming environment for every customer.” JSI...

Phase 2 trial to evaluate reduction in heavy drinking as measured by a change in the World Health Organization drinking risk levels1Trial is informed by results from Phase 1 studies that showed pharmacokinetic properties of OPNT002 well suited for ‘as needed’ administration, either in anticipation of drinking or once drinking has started2,3Target enrollment of approximately 300 patients; Results anticipated in 2023Alcohol Use Disorder is a chronic relapsing brain disease characterized by compulsive heavy drinking and is among the most prevalent mental health disorders globally4SANTA MONICA, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT) today announced that the first patient has been dosed in a Phase 2 clinical trial of OPNT002, nasal naltrexone, for the treatment of Alcohol...

SANTA MONICA, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) — Correction: Opiant Pharmaceuticals, Inc. (“Opiant” or “Company”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, reports that the company mistakenly reissued the press release this afternoon entitled, “Opiant Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).” This press release is a duplicate of the press release issued on December 20, 2021. The company regrets the error. For Media and Investor Inquiries:Ben Atkins, Opiant(310) 598-5410batkins@opiant.com  

Shelton, CT, Jan. 20, 2022 (GLOBE NEWSWIRE) — Hubbell Incorporated (NYSE: HUBB) today announced it will release its fourth quarter 2021 financial results prior to the opening of the market on February 3, 2021. The Company will then webcast its Analysts’ Conference Call to discuss the results at 10:00 AM ET. The full text of the press release announcing the results will be posted on Hubbell’s corporate website under the Press Release section. You can also access this information by going to www.hubbell.com and selecting “Investors” from the options at the bottom of the page and then “Press Releases” from the drop-down menu. The live audio of the conference call and accompanying materials will also be available and can be accessed by visiting Hubbell’s Events and Presentations section. You...

CALGARY, Alberta, Jan. 20, 2022 (GLOBE NEWSWIRE) — CE Brands Inc. (TSXV: CEBI; CEBI.WT) (“CE Brands” or the “Company”) is pleased to report that eBuyNow eCommerce Ltd. (“eBuyNow”), a wholly-owned subsidiary of CE Brands and strategic brand partner of Kodak Eastman Company (“Kodak”), has launched the KODAK Infinio F882 Outdoor Security Camera. The KODAK Infinio F882 is the fifth product developed by eBuyNow under the KODAK Smart Home brand, which includes Baby Monitors, Air Purifiers and Security Cameras. “The KODAK Infinio F882 Outdoor Security Camera is the latest addition to the KODAK Smart Home suite of products,” said Craig Smith, CEO of CE Brands. “We are excited to deliver this high quality, connected outdoor camera as our first product in our outdoor security category. We look forward to continuing to collaborate with our...

BALTIMORE, Jan. 20, 2022 (GLOBE NEWSWIRE) — Adams Diversified Equity Fund, Inc. (NYSE: ADX) announces the Fund’s investment returns for 2021. “We were pleased to generate a 29.8% return in 2021, outperforming our benchmark and three percentage points ahead of our peer group,” said Mark Stoeckle, CEO of Adams Funds. The total return on the Fund’s net asset value for 2021 was 29.8%, with dividends and capital gains reinvested. The comparable figures for the S&P 500 Index and Morningstar U.S. Large Blend Category were 28.7% and 26.7%, respectively. The total return on the Fund’s market price for the period was 29.9%. The Fund paid $2.98 per share in income dividends and realized capital gain distributions to shareholders in 2021, producing an annual distribution rate of 15.7%, exceeding the Fund’s annual 6.0% minimum distribution...

NEW HAVEN, Conn., Jan. 20, 2022 (GLOBE NEWSWIRE) — Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the “Company” or “Bioasis”), a biopharmaceutical company developing its proprietary xB3™ platform technology for the delivery of therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system (“CNS”) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, today announced that it has filed its unaudited quarterly financial statements and management’s discussion and analysis for the period ended November 30, 2021. All are available under the Company’s profile on SEDAR and on the Company’s website at www.bioasis.us/investors/. On behalf of the Board of Directors of Bioasis Technologies Inc.Deborah Rathjen, Ph.D., Executive Chair of the Board Follow on:FacebookInstagramLinkedInTwitter BTI-FIN About...

CALGARY, Alberta, Jan. 20, 2022 (GLOBE NEWSWIRE) — Enerflex Ltd. (TSX:EFX) (“Enerflex” or the “Company”), a leading supplier of products and services to the global energy industry, will release its fourth quarter and year end 2021 financial results after the market closes on February 23, 2022. These results will be available on the Enerflex website at www.enerflex.com. Analysts, investors, members of the media, and other interested parties are invited to participate in a teleconference and audio webcast on Thursday, February 24, 2022 at 8:00 a.m. MST to discuss the fourth quarter and year end 2021 financial results and operating highlights. To participate, please call toll free 1.844.231.9067 or 1.703.639.1277. Please dial in 10 minutes prior to the start of the call. No passcode is required. The audio webcast of the teleconference...